Sagent Pharmaceuticals data breach

Clerk's notes

Sagent Pharmaceuticals has officially reported a data security incident to authorities in New Hampshire. This disclosure, filed on May 1, 2026, indicates that unauthorized parties may have accessed the company's internal systems, potentially compromising personal information. The breach is currently under investigation to determine its full scope.

Individuals who received a formal notification letter from Sagent Pharmaceuticals are likely affected. These letters confirm that their personal information was contained within the compromised files. While the specific types of data exposed were not detailed in the public filing, the notification serves as an alert to potential risks.

If you have received a breach notification from Sagent Pharmaceuticals, it is prudent to take protective measures. This includes closely monitoring any accounts linked to the exposed information for suspicious activity. Consider placing a fraud alert or credit freeze with major credit bureaus as a precaution.

Review all financial statements and explanations of benefits for unusual charges or discrepancies. Change passwords for online accounts, especially if you reused them. Be vigilant against phishing attempts, which are fraudulent communications designed to trick you into revealing more sensitive data.

Understanding the full impact of a data breach can be complex. If you are among those who received a notification regarding the Sagent Pharmaceuticals incident, you may be eligible to have your situation reviewed by an attorney. This allows you to explore any potential legal recourse or compensation claims related to the exposure of your data.

If a notification letter about this breach reached you, see every New Hampshire data breach on file or browse all cases.